Podcasts about Roche

10pt penalty - but Everton out of the bottom 3. Patrick Boyland was at Goodison Park for an emotional night. Newcastle left Goodison bruised. Chris Waugh talks about fatigues and injuries… It's Spurs next, who lose after leading… again. Tim Spiers on Tottenham's shaky form. And we preview Man City's conquerors Aston Villa welcoming Arsenal. Art de Roche looks ahead to Unai Emery facing his old club. Host: Adam Leventhal Producer: Mike Zimmermann Executive Producer: Iain Macintosh Learn more about your ad choices. Visit megaphone.fm/adchoices

If approved, the merged airline would control more than 50% of Hawaii flights; drugmaker Roche to buy biotech startup working on obesity drugs; Spotify cuts 17% of workforce; Red Sea commercial ships attacked by Houthi rebels.

(00:00) Fred, Roche and Wallach go around the league to showcase some highlights (and lowlights) from Week 13. Twitter: @Touchernrich | @KenGriffeyrules Instagram: @Touchernrich | @fredtoucher  For the latest, Visit the show page on 985thesportshub.com. Follow 98.5 the Sports Hub on Twitter, Facebook and Instagram! Visit our channels on Twitch and Youtube!

Major averages ended lower today, but well off the lows. Wilmington Trust's Meghan Shue and Bespoke's Paul Hickey break down the market action. Morgan sits down with Commerce Secretary Gina Raimondo, Boeing Defense CEO Ted Colbert and Air Force Secretary Frank Kendall at the Reagan National Defense Forum. Blackstone's private equity group has $40B in dry powder it can deploy; group head Joe Baratta on the top opportunities his team sees and why public markets are more interesting than private right now. Jefferies analyst Sheila Kahyaoglu on industry implications for Alaska Air's purchase of Hawaiian Airlines. Plus, Roche buys its way into the obesity drug craze. 

Ben and Tom discuss ISM manufacturing data results from last Friday, the current employment situation, more merger action, bitcoin's recent rise, an attack on a US destroyer, and things to watch this week. For information on how to join the Zoom calls live each morning at 8:30 EST, visit https://www.narwhalcapital.com/blog/daily-market-briefingsPlease see disclosures:https://www.narwhalcapital.com/disclosure

If approved, the merged airline would control more than 50% of Hawaii flights; drugmaker Roche to buy biotech startup working on obesity drugs; Spotify cuts 17% of workforce; Red Sea commercial ships attacked by Houthi rebels.

The horseshoe crab has endured for over 450 million years. It has survived several mass extinctions including the one that killed off the dinosaurs. One reason for their incredible resiliency is their ability to fend off bacterial infection. Their blood contains cells that clot around invading bacteria, thereby protecting them from the attacking toxins.In this episode we talk with three experts about how this animal's unique blue blood has become essential to modern medicine. We also talk about why horseshoe crab populations are dwindling, and what biotech is doing to address the shortfall.Follow us on LinkedIn, X, Facebook and Instagram. Visit us at https://www.bio.org/

RACmonitor investigative reporter Edward M. Roche, an intrepid regular monitor of America's healthcare system, will return to Monitor Mondays for its next upcoming edition to report on how and why America's healthcare system has tied itself into a Gordian Knot of complexity: interwoven strands of conflicting rules and regulations, different payments for the same services, and a cumbersome patchwork quilt of facilities, big, small, and smaller. Roche, who recently introduced to Monitor Mondays listeners the concept of “smart hospitals,” will also take a stab at answering a key question: just how smart are they?Other broadcast segments will include these instantly recognizable features:• Monday Rounds: Dr. Ronald Hirsch, vice president of R1 RCM, will make his Monday Rounds.• The RAC Report: Healthcare attorney Knicole Emanuel will report the latest news about auditors.• Risky Business: Healthcare attorney David Glaser, shareholder in the law offices of Fredrikson & Byron, will join the broadcast with his trademark segment.• Legislative Update: Matthew Albright, chief leglistative affairs analyst for Zelis, will report on the latest legislative actions impacting the healthcare regulatory setting.

Our teacher today is Jeff Marrazzo, Co-Founder and former CEO of Spark Therapeutics. Under Jeff's leadership, this biotech company was the very first in history to receive FDA approval for a gene therapy. Spark has helped to ignite and expand the art of what's possible and how we will seek to treat and potentially cure hundreds of genetic conditions over the coming decades. Jeff provides us with an insider's overview of the biotechnology industry and shares the full story of Spark, from its humble origins in the labs of Children's Hospital of Philadelphia all the way through to its nearly $5 billion acquisition by Roche. I hope you enjoy our class with the inspiring Jeff Marrazzo.  For the full show notes, transcript, and links to mentioned content, check out the episode page here. ----- This episode is brought to you by Summus. Summus is a revolutionary health benefits solution, driving superior employee engagement while dramatically lowering your company's enterprise-level healthcare spend. They're completely transforming the world of health benefits by providing employers and their employees in any location, fast access to over 5,100 of the top medical specialists from America's very best medical centers for support across all health questions. If you're looking for a benefit that drives your employee engagement, truly takes care of your people in their most scary and vulnerable times, all while improving your healthcare ROI, visit GoSummus.info/AOI. This episode is brought to you by Hunt Club. Hunt Club unlocks relationships and helps companies grow. Whether it's recruiting your next hire, landing your next big partner, or financing your business, a trusted introduction always works more effectively. Hunt Club's tech-enabled search model leverages the largest community of its kind to refer amazing talent on your behalf. Additionally, its software program, Atlas, helps organize the entire network of a company or fund and assists in streamlining the right introductions. If you're looking for the ideal solution for all of your talent needs, visit HuntClub.com/AOI. ----- Art of Investing is a property of Pine Grove Studios in collaboration with Colossus, LLC. For more episodes of Art of Investing, visit staygrovey.com.  Stay up to date on all our podcasts by signing up to Colossus Weekly, our quick dive every Sunday highlighting the top business and investing concepts from our podcasts and the best of what we read that week. Sign up here. Follow us on Twitter: @ArtofInvest | @Buhrman_Rick | @PaulBuser | @JoinColossus Show Notes (00:06:20) - [First question] - Witnessing the impact of aiding others (00:10:45) - The genesis of the vision for Spark Theraputics (00:15:11) - Securing FDA approval (00:20:22) - Navigating the venture capital landscape (00:27:26) - Confronting periods of doubt (00:33:21) - The significance of gene therapy in the US (00:38:40) - Drawing inspiration for interdisciplinary collaboration (00:43:58) - Guidance for youth seeking to capitalize on opportunities (00:50:20) - Anticipating advancements in life sciences and healthcare (00:54:34) - The role of AI in advancing gene therapy (00:58:38) - Ways to engage with biotechnology (01:04:55) - Simplifying the complexities of biotechnology investment

Toujours rien. Deux mois après la disparition de Lina en Alsace, aucune nouvelle de cette adolescente de 15 ans partie de chez elle à pied pour rejoindre la gare de Saint-Blaise-la-Roche à 3 kilomètres. RTL révèle que les habitants de la Plaine ont été réentendus et on en parle avec Plana Radenovic du service police justice de RTL. Ecoutez L'invité de RTL Midi du 23 novembre 2023 avec Agnès Bonfillon et Eric Brunet.

Lina, 15 ans, a disparu le 23 septembre dans le Bas-Rhin alors qu'elle se rendait en fin de matinée vers la gare de Saint-Blaise-la-Roche en empruntant à pied un itinéraire d'environ trois kilomètres depuis son domicile dans une zone boisée et forestière au pied du massif des Vosges. Elle devait retrouver son petit ami à Strasbourg qui, ne la voyant pas arriver, avait donné l'alerte. Ecoutez RTL Evènement du 23 novembre 2023 avec Yannick Olland.

Vinene i afsnittet er skænket af Kjær og Sommerfeldt https://www.kjaersommerfeldt.dk/   Smagekasse: https://www.kjaersommerfeldt.dk/vin/smagekasser/smagekasse-dyk-ned-i-bourgogne-smagekasse-med-podcast-3-flasker/p-1026559/   …………………….   Igen skal vi blive klogere på inddeling af niveauer i Bourgogne og igen skal man have tungen lige i munden. Heldigvis er René certificeret bourgogne-underviser og ambassadør, så vi er hjulpet godt på vej!   Vi smager på tre vine fra området Côte Chalonnaise; to hvide lavet på chardonnay og en rød på pinot noir. Årgang 2019 og 2020. Og vi nørder selvfølgelig smag, duft, jordbunde, klima og klassifikationer.   Vinene er fra det danskejede hus Albert Sounit.   Kort over Côte Chalonnaise: https://www.bourgogne-wines.com/gallery_images/site/30476/42250/42527.jpg     Vi smager på   1) Domaine Albert Sounit, Bourgogne Blanc - Les Vignes de la Roche, Bourgogne, Côte Chalonnaise, 2020https://www.kjaersommerfeldt.dk/vin/hvidvin/maison-albert-sounit-bourgogne-blanc-les-vignes-de-la-roche-bourgogne-cote-chalonnaise-2020/p-1023171     2) Maison Albert Sounit, Rully Blanc 1. Cru - Les Raclots, Bourgogne, Côte Chalonnaise, 2019https://www.kjaersommerfeldt.dk/vin/hvidvin/maison-albert-sounit-rully-blanc-1-cru-les-raclots-bourgogne-cote-chalonnaise-2019/p-1022514/   3) Maison Albert Sounit, Mercurey Rouge - Vieilles Vignes, Bourgogne, Côte Chalonnaise, 2020https://www.kjaersommerfeldt.dk/vin/roedvin/maison-albert-sounit-mercurey-rouge-vieilles-vignes-bourgogne-cote-chalonnaise-2020/p-1023704/   .......................   Køb en signeret udgave af vores bog med 20% rabat her https://vinforbegyndere.com   Støt Vin for begyndere podcast her https://vinforbegyndere.10er.app/   Besøg os på Facebook og Instagram, hvor man kan se billeder af vinene og få tips til vin og mad sammensætning.   https://www.facebook.com/vinforbegyndere   https://www.instagram.com/vinforbegyndere   Web: https://www.radioteket.dk/   Kontakt: radioteket@radioteket.dk   Musik: Jonas Landin   Lyt vores bog som lydbog her: Køb den her https://www.saxo.com/dk/vin-for-begyndere-og-oevede_lydbog_9788773397374

Ecoutez les infos de la Loire avec le flash info de 19h00 de ce mercredi 22 novembre 2023. L'actualité à Saint-Etienne, Saint-Chamond, Roanne, Firminy, Montbrison, Rive-de-Gier, Saint-Just-Saint-Rambert, Le Chambon-Feugerolles, Riorges, Andrézieux-Bouthéon, Roche-la-Molière, Veauche, Unieux, Feurs, Villars, Sorbiers, La Ricamarie, Mably, Le Coteau, La Talaudière...

Ecoutez les infos de la Loire avec le flash info de 12h00 de ce mercredi 22 novembre 2023. L'actualité à Saint-Etienne, Saint-Chamond, Roanne, Firminy, Montbrison, Rive-de-Gier, Saint-Just-Saint-Rambert, Le Chambon-Feugerolles, Riorges, Andrézieux-Bouthéon, Roche-la-Molière, Veauche, Unieux, Feurs, Villars, Sorbiers, La Ricamarie, Mably, Le Coteau, La Talaudière...

Ecoutez les infos de la Loire avec le flash info de 18h00 de ce mercredi 22 novembre 2023. L'actualité à Saint-Etienne, Saint-Chamond, Roanne, Firminy, Montbrison, Rive-de-Gier, Saint-Just-Saint-Rambert, Le Chambon-Feugerolles, Riorges, Andrézieux-Bouthéon, Roche-la-Molière, Veauche, Unieux, Feurs, Villars, Sorbiers, La Ricamarie, Mably, Le Coteau, La Talaudière...

Inhalt:Sigrid Allerstorfer arbeitet im Bereich Market Access und Healthcare Management bei Roche Diagnostics. Die gebürtige Oberösterreicherin (Mühlviertel) und leidenschaftliche Forscherin, hat in Wien Neurobiologie sowie Genetik studiert und ihr Doktoratsstudium in der Krebsforschung absolviert. Wissenschaft und Forschung liegen ihr sehr am Herzen und so ist Sigrid Allerstorfer 2010 von der wissenschaftlichen Forschung in die Forschung der Pharmaindustrie bei Roche eingestiegen. Die Expertin betont den Wert und die Bedeutung von Diagnostik: Für jede medizinische Entscheidung und die Wahl der optimalen Therapie braucht man Diagnostik. Der Trend geht heute immer mehr in Richtung maßgeschneiderte Therapie (z.B. bei Brustkrebs), entsprechend granulärer wird auch die Diagnostik.Außerdem Thema dieser Podcast-Episode: weitere aktuelle Trends im Bereich Diagnostik, wie Disease-Management-Programme (zur kontinuierlichen Versorgung chronisch kranker Personen), Risikoschätzungen und Test auf Vorliegen von Risikofaktoren sowie Lifestyle-Parameter, etwa Speichelanalysen zur Bestimmung des Mikronährstoff-Spiegels. Weitere spannende Aspekte, auf die Sigrid Allerstofer im Gespräch eingeht, sind Digitalisierung, digitale Gesundheitsanwendungen (DiGA), Datenschutz und KI. Digitalisierung bringt Forschungsdaten und ist dadurch ein großer Schritt in der Diagnostik und Forschung. In diesem Zusammenhang ein wichtiges Thema: die nötige Bewusstseinsbildung, um der Bevölkerung Bedenken zu nehmen und den entscheidenden Nutzen für jeden einzelnen aufzuzeigen, z.B. bei Krankenhausbehandlungen im Ausland Zugriff auf die eigenen Gesundheitsdaten zu haben. In der KI sieht die Forscherin eine sinnvolle Hilfe beim Lesen von Bildern oder bei der Optimierung von Workflows und Prozessen, um knappe personelle Ressourcen möglichst effizient einzusetzen.  Abschließend schildert Sigrid ihre Wünsche für die Zukunft. Allen voran, dass wissenschaftlich fundierte, anerkannte diagnostische Tests oder Innovationen schneller ins System kommen, damit man das volle Potenzial zum Wohle der PatientInnen ausschöpfen, von Anfang an die jeweils optimale Therapie anwenden und gleichzeitig sogar Behandlungskosten einsparen kann. Timestamps: (02:30) - Vorstellung Sigrid Allerstorfer & Roche Diagnostics (05:38) - Differenzierung Diagnostik (11:21) - Disease Management Programme (15:39) - Digitalisierung in der Diagnostik & Datenschutz (35:14) - Digitale Gesundheitsanwendungen in Österreich (DiGA) (52:09) - Kommunikation und Marketing (01:02:40) - Summary & Verabschiedung Visit us on: LinkedIn | Facebook | InstagramRené Neubach: LinkedIn | Facebook | InstagramDominik Flener: LinkedIn | Facebook | Instagram 

Ecoutez les infos de la Loire avec le flash info de 16h00 de ce mercredi 22 novembre 2023. L'actualité à Saint-Etienne, Saint-Chamond, Roanne, Firminy, Montbrison, Rive-de-Gier, Saint-Just-Saint-Rambert, Le Chambon-Feugerolles, Riorges, Andrézieux-Bouthéon, Roche-la-Molière, Veauche, Unieux, Feurs, Villars, Sorbiers, La Ricamarie, Mably, Le Coteau, La Talaudière...

On episode 3 of The Coaching Playbook series 1 host Adrian O'Sullivan chats to Eoin Roche. Eoin is current head coach with Na Fianna Senior Hurlers, DCU Fitzgibbon, and Dublin U14 manager. Shane and Adrian discuss all things coaching, his approach to analysis, engaging players, and more!  Series 1 is sponsored by ⁠@irishscnetwork⁠ a diverse coaching network that includes members from a wide range of fields. From S&C coaches, sports scientists, and physiotherapists to Students, Hobbyists, and anyone with an interest in coaching, at all levels of sport and health, from grassroots to elite performance. As a listener of “ The Coaching Playbook”, The Irish S&C Network is offering a 30-day free trial for all of our listeners. Simply use the code "ISCNPLAY" at checkout to access this fantastic opportunity to connect and learn from experienced practitioners in an open and honest environment. https://www.irishscnetwork.com/   Find Eoin here: https://twitter.com/rochey1978 https://twitter.com/NoPlanBGAA  Find Adrian here: https://twitter.com/sullylimerick1  Follow The Sideline Live Social Media channels: https://twitter.com/thesidelinelive https://www.instagram.com/thesidelinelive Recorded using Samson Q2 microphone, Edited using GarageBand If you are looking to set up your own podcast get in touch with the Prymal Productions team ⁠⁠⁠www.prymal.ie⁠ --- Send in a voice message: https://podcasters.spotify.com/pod/show/the-sideline-live/message

Tune in for a sneak peek of GOLD's latest Catalyst interview with Dr Peter Ahnesorg, Global Hematology Franchise Head, Roche.   In this exclusive teaser of the full interview, Peter talks about why he left research for industry, Roche's commitment to ensuring equitable access to its medicines and what he believes are the qualities of a good leader today.   If you're interested in learning more about the topic areas discussed in this episode, check out the following content: Podcast: Changing the tide on health inequities Podcast: Do happy employees equal better innovation? Last week's podcast: A high-speed chase for oncology innovation

Welcome to Episode 172 of DividendTalk, where we delve into the intriguing world of bonds and ask the burning question: should we own some? We kick off with the latest financial news, including Germany's reforms to boost its tech industry and Alibaba's historic introduction of dividends. Siemens, a powerhouse in the corporate landscape, reports record-breaking earnings, paving the way for a discussion on the pros and cons of owning bonds. At the heart of the episode, we break down the fundamentals of bonds—what they are, the different types (including government, municipal, and corporate bonds), and their inherent risks and rewards. Derek and eDGI explore the stability and predictable income bonds offer, contrasting it with the risks, including the dreaded duration risk and the potential lack of income growth compared to dividend hikes. The main question lingers: Should we own bonds? We share our perspectives, with Derek emphasizing his current focus on growth and eDGI considering bonds as part of a savings plan for future investment. Asset allocation strategies, such as the classic 60/40 portfolio and age-based allocations, are dissected to provide listeners with practical insights. Wondering where to buy bonds? We've got you covered, discussing options like brokers, ETFs, and even buying directly from the U.S. government. Armed with this knowledge, the hosts reflect on whether owning bonds aligns with their investment strategies at this stage. But that's not all! The episode is rounded off with engaging listener questions covering topics like stock screening, sector preferences, and intriguing hypothetical scenarios. Tune in to hear the hosts' takes on various tickers, from Roche's dip to eDGI's frustration with Bayer Whether you're a seasoned investor or just starting your financial journey, this episode of DividendTalk offers valuable insights and answers to your burning questions. Join us for a deep dive into the world of bonds and financial strategies that could shape your investment decisions. Stock Screener article: https://www.europeandgi.com/how-to/dividend-stock-screener/ Join us on Facebook: https://www.facebook.com/groups/dividendtalk

As a leader, the more genuine and authentic you become in your communication and connections, the easier your job gets. One thing is true of people from all generations: People stay when they feel valued. In this week's episode of the Lead Up Podcast, my guest Geoffrey Roche, and I discuss the importance of leading from the heart and how to lead with authenticity that displays appreciation to your team. If you enjoyed this episode, be sure to leave a 5-star review on your streaming platform. Mike encourages you to reach out to him through: Mike@harbourresources.com, to let him know your thoughts on this episode & to share some topics you would like him to speak on in the future.

Die Basler Regierung gab am Freitag die Verabschiedung des Bebauungsplans für das Südareal der Roche bekannt. Platz in diesem Plan hätte es auch für ein drittes Hochhaus. Für einen dritten Turm hat Roche aktuell aber noch keine Pläne. Ausserdem: * Nachwuchsförderung junger Autorinnen und Autoren am Literaturfestival Buch Basel * Wochengast: Hendrik Scholl, Professor für Ophthalmologie an der Universität Basel und klinischer Leiter des Instituts für Molekulare und Klinische Ophthalmologie Basel (IOB) Weitere Themen: - Wochengast: Hendrik Scholl

Der Pharmakonzern will ein weiteres Forschungs- und ein weiteres Produktionsgebäude bauen. Und die Regierung hat den Bebauungsplan für das Roche-Areal zum Rhein hin bewilligt. Hier soll anstelle alter Gebäude ein Park entstehen. Ein 3.Turm ist derzeit nicht geplant.  * Geschäftsführer der Kaserne Basel geht nach 15 Jahren * Martin Rueda wird weiterer FCB-Assistenztrainer 

Leonard Slatkin - Billy Roche - Bernard Canavan

Rebecca is a Co-Founder and General Partner at Canvas Ventures where she leads early-stage investments in Fintech, Healthtech, and AI. Rebecca has been named to the Forbes Midas List five years running, a Woman to Watch: Senior Deal Maker by the Wall Street Journal, and a Top Woman VC by the New York Times. Some of her notable investments include Luminar (NASDAQ: LAZR), Lending Club (NYSE: LC), Practice Fusion (acq Allscripts), Gabi (acq Experian), Check (acq Intuit), RelateIQ (acq Salesforce), CrowdFlower (acq by Appen), Viewics (acq Roche), FutureAdvisor (acq Blackrock), and Figure8 (acq Appen).  Before founding Canvas, Rebecca served as a General Partner at Morgenthaler Ventures. During her time at Morgenthaler, one of her early investments, Doximity (NYSE: DOCS), went public in 2021 and was one of the year's largest IPOs. Before that, she was the VP of NextCard. At NextCard, the first online credit card company, Rebecca helped scale the company from 30 people to 1300 and an IPO.  You can learn more about:  How to invest in the world's changing entrepreneurs   Founding and managing a leading VC firm  How to be a value-adding board member  ===================== YouTube: @GraceGongCEO Newsletter: @SmartVenture LinkedIn: @GraceGong TikTok: @GraceGongCEO IG: @GraceGongCEO Twitter: @GraceGongGG =====================   Join the SVP fam with your host Grace Gong. In each episode, we are going to have conversations with some of the top investors, superstar founders, as well as well-known tech executives in silicon valley. We will have a coffee chat with them to learn their ways of thinking and actionable tips on how to build or invest in a successful company.

This episode features Geoffrey M. Roche, Director of Workforce Development at Siemens Healthineers and Industry Lead at National Health Care Practice & Paul Schrimpf, Proprietor and Entrepreneur at Cyrall. Here, they discuss the issues surrounding the nursing workforce crisis, what the root causes of the shortage are, specific examples of how to mitigate shortages, and more.

In der Nachmittagsfolge begrüßen wir heute Manuel Opitz, CEO und Co-Founder von Deepeye Medical, und sprechen mit ihm über die Seed-Runde in Höhe von 2,5 Millionen Euro.Deepeye Medical hat gemeinsam mit Augenärztinnen und Augenärzten sowie Pharma- und Diagnostikherstellern einen KI-Assistenten für die Netzhauttherapie entwickelt, um die Behandlung der altersbedingten Makuladegeneration (AMD) zu verbessern. AMD ist eine schwerwiegende Augenerkrankung und die häufigste Ursache für Erblindung. Das Startup verwendet einen Algorithmus, der auf dreidimensionalen Augentomographien basiert, um Netzhautbilder zu analysieren. Dies ermöglicht Ärztinnen und Ärzten, personalisierte Behandlungsvorschläge zu erstellen und die Erfolgsaussichten der Therapie zu erhöhen. Der Algorithmus hat von hunderttausenden Netzhaut-Scans gelernt und bietet datenbasierte Informationen zur besseren Einschätzung der Krankheitsaktivität und des Verlaufs. Die Software ergänzt die klinische Expertise und hilft den Behandelnden, das Krankheitsbild besser zu verstehen und Therapieintervalle zu optimieren. Sie erleichtert darüber hinaus auch die Aufklärung der Patientinnen und Patienten. Deepeye Medical wurde im Jahr 2021 von Ratko Petrovic und Manuel Opitz in München gegründet. Das bayerische Startup hat bereits Erfolge in der Zusammenarbeit mit großen Pharmaunternehmen wie Novartis, Bayer und Roche verzeichnet. Die KI-Plattform wird auch von anderen Unternehmen sowie von Ärztinnen und Ärzten genutzt, um wertvolle Erkenntnisse aus vorhandenen Therapiedaten zu gewinnen.Nun hat das Münchner MedTech in einer Seed-Runde 2,5 Millionen Euro unter der Führung von YZR Capital eingesammelt. Außerdem beteiligte sich Arve Capital an der Runde. Zudem hat sich Bayern Kapital an Deepeye Medical beteiligt. Zu der Gesamtsumme der Seed-Finanzierungsrunde zählen auch Forschungs- und Entwicklungszuschüsse mit dazu. Das Startup plant mit dem frischen Kapital seine KI-basierte Plattform weiterzuentwickeln und bis zum Jahr 2024 eine patientennahe Therapieentscheidungshilfe anzubieten. Das Ziel ist dabei, bis zum Jahr 2030 eine Million Menschen vor Erblindung zu bewahren, indem sie Augenärztinnen und -ärzten entscheidende datengestützte Informationen zur Verfügung stellen.

Ellen Roche is an associate professor of mechanical engineering and the associate head of the Department of Mechanical Engineering at MIT. Her research team develops new devices and therapeutic strategies for repairing the heart and other tissues. Here, she speaks with MIT President Sally Kornbluth about her work, the advantages of taking a nonlinear route to one's chosen career, and the importance of saying "yes" to unexpected opportunities.Links:Ellen RocheTherapeutic Technology Design and Development LabVideo: Patient-specific, 3D-printed, soft-robotic heartsDassault SystèmesInstitute for Medical Engineering and ScienceTimestamps:(03:35) - Potential for 3D-printing hearts(08:14) - Hydrogels(17:33) - On AIShow notes and transcript:https://news.mit.edu/podcast/podcast-curiosity-unbounded-episode-6-healing-ailing-heartJoin the mailing list or send us feedback:https://eepurl.com/ixPQPA

Whether it's disagreements with your partner or clashes within your team, one thing is clear – conflict is a part of life. Dr. Nate Regier understands that conflict is unavoidable, but he believes it can be turned into something positive. With his framework Compassionate Accountability, Dr. Regier has helped many groups use conflict as a catalyst for growth and positive change.Dr. Nate Regier is an author and keynote speaker. He's the founder and CEO of Next Element, a global leadership consulting and training firm. He has helped clients like Healthcare Corporation of America (HCA), Blue Cross Blue Shield, and Roche for over a decade, increasing profitability through reduced turnover while significantly enhancing teamwork and work relationships.In this episode, Dart and Nate discuss:- How to de-dramatize an organization- The definition of conflict and how to address it productively- The three roles in every drama and how to pinpoint them at work- The myths that these roles believe- Universal principles we can use when designing work- How to hold yourself accountable- Having a compassion mindset- The 3 narratives of struggle that can get management into trouble- And other topics…Dr. Nate Regier is an author, keynote speaker, and the founder and CEO of Next Element, a global leadership consulting and training firm that works to bring Compassionate Accountability to the workplace. As a former practicing psychologist and expert in social-emotional intelligence, Nate has helped clients like Healthcare Corporation of America (HCA), Ascension Health, Blue Cross Blue Shield, CarFax, and Roche save thousands in turnover and dramatically increase and improve teamwork and work relationships. Nate received his Ph.D. in psychology from the University of Kansas. He is recognized as a Top 100 keynote speaker, a Process Communication Model® Certifying Master Trainer, and the author of four books on interpersonal communications. He has served as an adjunct professor for Conflict Resolution at Pepperdine University for over a decade and is also a founding member of the Changing Work Collective. Resources mentioned:Compassionate Accountability, by Nate Regier: https://www.amazon.com/Compassionate-Accountability-Leaders-Connection-Results/dp/1523004533 Conflict Without Casualties, by Nate Regier: https://www.amazon.com/Conflict-without-Casualties-Compassionate-Accountability/dp/1523082607 Connect with Nate:www.Next-element.com

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: US approval for Lilly's obesity drug; a look at the future of the obesity market; BMS's ADC deal; Roche's MS plans; and one Chinese firm's CAR-T plans. https://scrip.citeline.com/SC149349/Quick-Listen-Scrips-Five-MustKnow-Things

On today's episode, we're diving deep into a topic that's dear to my heart - networking. After losing a job I held for nearly a decade, I had to start from scratch and it was during this challenging phase that I realized the immense power of networking. To discuss this further, we have on board the insightful Greg Rochet, a successful business executive and a self-proclaimed introverted networker. We talk about everything from building meaningful connections to nurturing relationships and striking that fine balance between work, networking, and life. Interestingly, we also discuss the impact of LinkedIn on our networking strategies, as well as tips to engage with those who are ahead in our career journey. Listen in, as we unwrap practical insights that can transform your professional life through networking. Don't miss this chance to elevate your career. So, tune in, connect, and let's grow together! Show Highlights: Greg's personal journey from being networking-avoidant to networking expert. How Greg balances a demanding full-time job, a busy personal and family life, and his “side hustle” as a content creator and networking coach.  What it truly means to be an introvert - versus what many people think it means. The mindset shift that many introverts need to make to change their views about networking, and how uncomfortable it may be.  How to build and expand your meaningful relationships by starting with existing connections.  The easy first step to take to get over feeling awkward about networking. The AIR framework for giving when networking - advice, introductions, and recommendations.  Greg's LinkedIn posting strategy, and how he creates meaningful content to engage with his network there every weekday. Follow and Review: We'd love for you to follow us if you haven't yet. Click that purple '+' in the top right corner of your Apple Podcasts app. We'd love it even more if you could drop a review or 5-star rating over on Apple Podcasts. Simply select “Ratings and Reviews” and “Write a Review” then a quick line with your favorite part of the episode. It only takes a second and helps spread the word about the podcast. People & Resources Mentioned In This Episode: Greg Roche - LinkedIn The Introverted Networker Newsletter The Fast and Easy Guide to Networking for Introverts: How to Connect Without Going to Events, Making Cold Calls, or Sending Spammy Emails by Greg Roche Idea Sex In Talent Management | Greg Roche | DisruptHR Talks Give and Take: A Revolutionary Approach to Success by Adam Grant Influence: The Psychology of Persuasion, Revised Edition Paperback by Robert B. Cialdini Connect with Jennifer: Send her a message: https://jennifermcclure.net/contact On LinkedIn: http://www.linkedin.com/in/jennifermcclure On Twitter https://twitter.com/JenniferMcClure On Instagram: https://www.instagram.com/jennifer_mcclure/ On Facebook http://www.facebook.com/JenniferMcClureSpeaker *** Episode Credits: If you like this podcast and are thinking of creating your own, consider talking to my producer, Emerald City Productions. They helped me grow and produce the podcast you are listening to right now. Find out more at https://emeraldcitypro.com. Let them know I sent you.

Episode Summary: Our guest on today's podcast is Jim Bishop, the founder of Conjunction Leadership, an acclaimed business specializing in executive development, corporate leadership, and human performance. With over two decades of immersive experience, Jim has coached executives, nurtured diverse teams, and spearheaded the modernization of leadership systems in various business units worldwide. In this episode, we delve into Jim's journey, his collaborative ventures with industry titans, and the evolution of his transformative leadership approach. Episode Highlights: Jim Bishop's immersive journey in executive development, corporate leadership, and human performance spans over two decades. With a global presence, Jim has provided executive coaching and team development solutions to renowned organizations, including Eli Lilly, Roche, and Elanco. The birth of Conjunction Leadership in 2020 was catalyzed by Jim's realization of the critical role played by visionary leaders who prioritize personal growth and subsequently revitalize organizational culture. Jim is a certified coach by the International Coaching Federation (ICF) and a Certified Leadership Facilitator with Blanchard, infusing science and art into his methodology. At Conjunction Leadership, their holistic approach empowers executives through executive coaching, corporate culture consulting, and team effectiveness programs designed for personal and professional development within volatile contexts. The exclusive DISRUPT, BRIDGE, and GROW process, pioneered by Conjunction Leadership, guides leaders on a transformative journey of self-discovery, mindset shifts, and measurable growth. Join us as we gain valuable insights from Jim Bishop's wealth of experience in transformative leadership and explore how Conjunction Leadership is revolutionizing executive development and leadership effectiveness. Twitter: https://twitter.com/conjunctionleadFacebook: https://www.facebook.com/conjunctionleadershipInstagram: https://www.instagram.com/conjunctionleadership/Youtube: https://www.youtube.com/channel/UCY0ZTxlt6B7_XJdbuC6eR2wLinkedIn: https://www.linkedin.com/in/jamesdbishop/

Hablamos de la detección temprana del cáncer de mama.

Listen in to the newest episode of the GOLD podcast, in which Jade digs deep into the diversity, equity and inclusion (DE&I) space with Marion Brooks, Vice President and US Country Head, Diversity, Equality and Inclusion, Novartis. In the interview, the pair discuss why Marion left a career in commercial for DE&I, the need for more action on health inequities, Novartis's approach to creating a more diverse medical workforce and much more. If you're interested in learning more about the topic areas discussed in this episode, check out the following content:   Roche's Davidek Herron: My journey with diversity, equity and inclusion 4 top tips to create the perfect ERG Last week's podcast: Why HCPs are losing trust in pharma marketing

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: CEOs on global tensions; Roche's new Alzheimer's contender; Sanofi eyes external deals; investors' reactions to clinical data; and Korean licensing pitfalls https://scrip.citeline.com/SC149308/Quick-Listen-Scrips-Five-MustKnow-Things

A Lorice Scalise, CEO da Roche Farma, é uma dessas pessoas que você se encanta ao ouvir ela falar com paixão da sua vida, Paulo "PC" Crepaldi conversou sobre o futuro da Roche, a visão da executiva sobre o mercado farmacêutico no meio dessa transformação digital e claro, sobre o empoderamento de gêneros.Obrigado por ouvir, acesse @viaoral ou nosso site viaoral.com.br

SAMEDI 04 NOVEMBRE 2023 Philippe Bardet - Maison Jean Loron (Beaujolais/Bourgogne)   Installée entre la Roche de Solutré en Mâconnais et le Moulin à-Vent en Beaujolais, la Maison Jean Loron est l'un des plus anciens et plus grands propriétaires viticoles du Sud de la Bourgogne. Fondée il y a plus de 300 ans par Jean Loron, la Maison cultive aujourd'hui plus de 150 ha de vignes réparties sur plusieurs domaines et châteaux viticoles.   Nicolas Paradis - Château (Paris)   Ô Château séduit depuis plus de 15 ans amateurs de vins, novices, professionnels ou touristes grâce à ses activités variées. Ce véritable lieu de rencontre dans le paysage parisien, compte plus de 1000 références et 50 vins au verre et propose une offre de restauration et de service inédites. Nicolas Paradis, entrepreneur dans l'âme et passionné de vin et de gastronomie, dénombre aujourd'hui 8 adresses incontournables à Paris et en Ile-de-France proposant une offre de produit et de services autour du vin.  

Hola, bienvenidos a AjiTerapia, el podcast donde hablamos de temas relevantes para la salud mental y el bienestar integral. En este episodio, nos centraremos en la luna, una de las fuerzas más poderosas de la naturaleza. Invitados Para hablarnos de la luna, tenemos el placer de contar con la presencia de: Carmen S. Colón Collazo, trabajadora social y terapeuta familiar. Dr. José Rodríguez Roche, psicólogo y psicoterapeuta. Carlos A. Laster Torres, artista polifacético. Conversación Carmen: La luna ha sido una figura importante en muchas culturas a lo largo de la historia. ¿Qué significado tiene para ustedes? Dr. Rodríguez: La luna representa muchos conceptos, como la feminidad, la fertilidad, la intuición y la magia. También es un símbolo de transformación y cambio. Carlos: Para mí, la luna es una fuente de inspiración. Me gusta contemplarla y ver cómo cambia de forma y color cada noche. Amaury: La luna me recuerda a mi infancia. Recuerdo quedarme despierto hasta tarde para verla y hacer deseos. Carmen: La luna también tiene un impacto en nuestro cuerpo físico y emocional. ¿Podrían hablarnos un poco sobre eso? Dr. Rodríguez: La luna regula nuestro ciclo menstrual, nuestros niveles de hormonas y nuestro sueño. También puede afectar nuestro estado de ánimo, nuestra energía y nuestra creatividad. Carlos: La luna puede ser una herramienta para la sanación y el crecimiento personal. Por ejemplo, se puede utilizar para la meditación, la astrología y la terapia de luz. Amaury: La luna me ayuda a conectarme con mi lado espiritual. Me gusta salir a la playa a meditar bajo la luz de la luna. Conclusión La luna es una fuerza poderosa que puede tener un impacto significativo en nuestras vidas. Es importante entender su significado y su impacto para poder aprovechar sus beneficios. Despedida Gracias por escuchar AjiTerapia. Nos vemos el próximo episodio. Su anfitrion, Walter Rivera Santos Email: Events@BrainThemePark.com Phone: 1-787-223-2817 

The global pharmaceutical industry experienced extraordinary profits due to the circumstances of the Covid-19 pandemic, but how are players coping now that the Covid effect has receded? We speak to Deepti Saraf, General Manager of Roche Malaysia on the current pharmaceutical landscape, as well as efforts to improve affordability and accessibility of life-saving drugs.

This time, it's the company's holiday party.

Shannon Banks is managing director of Be Leadership, and an award-winning facilitator, consultant, and coach. A pioneer in the field of social leadership, she founded her company in 2014 to help organizations bring their purpose to life through their people. In this episode, we'll dive into her steadfast belief that it is leaders that have the power to ignite purpose through social leadership.Shannon has delivered quality, bespoke work to diverse clients across many sectors, including Roche, BNP Paribas, and the UK House of Commons and has partnered with world-changing organizations such as Teach for India, Grameen Foundation, and Siel Bleu.She spent twenty years in the technology industry, including seventeen years at Microsoft where she held a variety of global leadership roles across the business and HR. She has won international awards for her work in leadership development and talent management and is a sought-after public speaker.She is coauthor of the third edition of the field-defining book Optimizing the Power of Action Learning. Her forthcoming book Because: 12 Essential Skills for Connecting How you Lead with Why will be released October 2023._________________________________________________________________________________________In this episode, she shares:The 12 leadership traits that can elevate you as a leader—both relationship-based and contextual-based Why now, more than ever, being a social leader is critical as technology cements itself into our work environment The difference between strengths, values and passions—and how they intermingle to optimize your purpose _________________________________________________________________________________________Episode Timeline:00:00—Highlight from today's episode00:54—Introducing Shannon + The topic of today's episode2:55—If you really know me, you know that...3:49—What is your definition of strategy?4:25—Could you talk to us about how your career inspired your book?5:35—Why did you name your company "BE" leadership?7:28—Could you lead us through your the 12 skills leaders must have?9:20—Talk to us about your definition of social leadership12:40—How can executives find their own purpose to help others to connect to theirs?16:50—What's a powerful insight you could share for leaders on how to use this passion in the workplace?18:11—Creating change at scale is incredibly difficult—could you share your story of living in Russia that illustrates this?22:24—How can people follow you and connect with you to continue learning from you?__________________________________________________________________________________________Additional Resources: Author Website: https://shannonbanksauthor.com/Company Website: https://be-leadership.com/LinkedIn: https://www.linkedin.com/in/shannon-banks-be-leadershipTwitter: https://twitter.com/ShannonB

Seven-time NAHA winner and Redken Master Artist, Ruth Roche has traveled the world sharing her vast experience and knowledge with hairdressers. Known for her versatility, from cutting-edge looks to low-maintenance chic, Ruth has worn many hats: NYC salon owner, editorial stylist, top educator, and celebrity stylist.Today I get to sit down with Ruth and talk and laugh with her as we share her hair journey.Ruth shares how, and the age of just 22, she applied and was chosen to be on Trevor Sorbie's team‘Connect to the audience by becoming one of them instead of talking at them'Learn how Ruth overcame Imposter Syndrome with humourRuth shares how she wishes all hairdressers pursued learning all the way throughout their careerRuth shares the most difficult time in her lifeWhat Ruth would do if she could not do hair anymore?⭐️⭐️⭐️ Check out more episodes and the videos at https://chrisbaran.com/podcast ⭐️ Join our FREE Facebook community for Salon Team Trainers today. https://facebook.com/groups/salonteamtraining ✅ Exclusive content on how to implement and scale your salon training the easy way ✅ Save time and learn what works from people just like you ✅ Get back to your mission of building the salon business and creating more jobs Learn more here - https://bit.ly/trainersplaybook Join our FB group - https://facebook.com/groups/salonteamtraining Follow us on IG - https://instagram.com/coachchrisbaran

Daiichi Sankyo has drawn more value from its antibody-drug conjugate pipeline via a $4 billion deal with Merck & Co. On the latest BioCentury This Week podcast, BioCentury's editors analyze the deal in the context of the burgeoning ADC space and size up the assets that Merck is in-licensing as well as how the deal fits with Daiichi's pipeline strategy.The editors break down Monday's $7.1 billion deal by Roche for the Telavant subsidiary of Roivant Sciences, the latest in the evolving TL1A space; and offer highlights from BioCentury's deep dive into how academics and biotechs are expanding the therapeutic potential of base editors.

In der heutigen Folge „Alles auf Aktien“ sprechen die Finanzjournalisten Philipp Vetter und Holger Zschäpitz über eine Crash-Warnung des "Wall Street Journal", neue Hoffnung bei Varta und Chevrons Milliarden-Deal. Außerdem geht es um VW, Münchener Rück, Talanx, Nemetschek, Philips, Roche, Marathon Digital, Riot Platforms, Coinbase, VanEck Crypto and Blockchain Innovators ETF (WKN: A2QQ8F), iShares MSCI World Energy Sector ETF (WKN: A2PHCF), iShares Global Clean Energy (WKN: A0MW0M), Deutsche Pfandbriefbank, Nagarro, Flatexdegiro, Hellofresh, Zalando, Siemens Energy, SGL Carbon, Tui, Nordex, Encavis, SMA Solar, Lanxess, Brenntag, ProSieben.Sat.1, Amazon, Alphabet, Micorsoft, Apple, BlackRock, Meta. Wir freuen uns an Feedback über aaa@welt.de. Ab sofort gibt es noch mehr "Alles auf Aktien" bei WELTplus und Apple Podcasts – inklusive aller Artikel der Hosts und AAA-Newsletter. Hier bei WELT: https://www.welt.de/podcasts/alles-auf-aktien/plus247399208/Boersen-Podcast-AAA-Bonus-Folgen-Jede-Woche-noch-mehr-Antworten-auf-Eure-Boersen-Fragen.html. Im WELTplus-Abo enthalten ist unter anderem auch dieser Artikel zu Sahra Wagenknechts Wirtschaftspolitik, die in der aktuellen Folge besprochen wird: https://www.welt.de/wirtschaft/plus248157204/Sahra-Wagenknechts-Steuerversprechen-an-die-kleinen-Millionaere.html Disclaimer: Die im Podcast besprochenen Aktien und Fonds stellen keine spezifischen Kauf- oder Anlage-Empfehlungen dar. Die Moderatoren und der Verlag haften nicht für etwaige Verluste, die aufgrund der Umsetzung der Gedanken oder Ideen entstehen. Für alle, die noch mehr wissen wollen: Holger Zschäpitz können Sie jede Woche im Finanz- und Wirtschaftspodcast "Deffner&Zschäpitz" hören. Impressum: https://www.welt.de/services/article7893735/Impressum.html Datenschutz: https://www.welt.de/services/article157550705/Datenschutzerklaerung-WELT-DIGITAL.html

US futures are pointing to a lower open as of 04:45 ET. European equity markets had opened mixed to higher but are now largely down, having followed broad weakness in Asian markets. Geopolitics and bond yields remain the main themes. Some discussion of how atypical global macro theme dominance this earnings season is capping gains even on upside surprises. Attention also turns to key tech earnings later this week. Companies Mentioned: Textainer, Roche, Roivant Sciences, Pfizer, Hon Hai

What strategies can healthcare leaders employ to enhance and strengthen the workforce? In this episode, Geoffrey Roche talks about the need for a sustainable workforce in healthcare and how this can be achieved through innovative partnerships and AI solutions. He advocates for collaborative initiatives, including innovative solutions and extended reality technology, to promote STEM healthcare careers and ensure equitable healthcare delivery reflective of diverse patient demographics. Learn how to improve access, lift communities, and provide equity in the workplace!  Click this link to access the show notes, transcript, and resources: https://outcomesrocket.health/ 

S&P Futures are [using lower this morning as the 10yr Treasury yield hit 5%. Earning and Geopolical issues remain market drives and the dysfunction is Washington DC remains a negative for the markets. This afternoon we have earnings reports due out from WHR, CLF, CCK LOGI & PKG. Chevron announced a deal to acquire Hess in a 53b deal. Roche agreed to buy Telavant Holdings from Roivant Sciences and Pfizer in a deal worth up to $7.25 billion. In Europe, stocks are moving lower with weakness in the autos, industrials and real estate sectors. Oil prices are slightly lower as a flurry of talks are being held in the Middle East aimed to prevents the Israel / Palestine conflict from expanding.

Scott Mason talks with NBC Sports Philadelphia Senior Producer Dan "Boonie" Roche about the Jets' week 6 matchup against the Philadelphia Eagles! Dan shares his thoughts on the Eagles' strengths and weaknesses offensively, Jalen Hurts and the supporting cast around him, the Eagles' strengths and weaknesses defensively, expectations for the game in week 6, key matchups, predictions, which extremely important starters will be missing for the Eagles on Sunday, and much more! Check out the Play Like A Jet YouTube channel featuring Luke Grant's full All-22 film breakdown of Quinnen Williams https://www.youtube.com/watch?v=y7RkSWhZUxw&t=206s Check out the Play Like A Jet store and get your "Play Like A Jet" logo shirt RIGHT NOW! Hoodies, hats, mugs, etc.....also available! https://www.teepublic.com/t-shirt/19770068-play-like-a-jet-logo-shirt?store_id=717242 To advertise on Play Like A Jet, please contact: Justin@Brokencontrollermedia.com Learn more about your ad choices. Visit megaphone.fm/adchoices